Zydus Fights For Right To Make Generic Strattera
Zydus Pharmaceuticals USA Inc. has launched a suit seeking permission to manufacture a generic version of Eli Lilly & Co.'s attention deficit hyperactivity disorder drug Strattera, arguing it is not bound...To view the full article, register now.
Already a subscriber? Click here to view full article